Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Primary Myelofibrosis × Everolimus × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Renal Cell 4 Neuroendocrine Tumors 3 Neoplasm Metastasis 2 Glioma 2 von Hippel-Lindau Disease 1 Waldenstrom Macroglobulinemia 1 Vascular Malformations 1 Thymus Neoplasms 1 Skin Neoplasms 1 Sarcoma 1 Pheochromocytoma 1 Paraganglioma 1 Nevus 1 Neoplasms, Plasma Cell 1 Multiple Endocrine Neoplasia Type 1 1 Metastatic Digestive System Neuroendocrine Tumor G1 1 Lymphoma 1 Lymphangioma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hereditary leiomyomatosis and renal cell cancer 1 Hemangioma 1 Hemangioendothelioma 1 Glioblastoma 1 Diffuse Intrinsic Pontine Glioma 1 Colorectal Neoplasms 1 Clear-cell metastatic renal cell carcinoma 1 Brain Neoplasms 1 Astrocytoma 1 Arteriovenous Malformations 1 Advanced Lung Neuroendocrine Tumor 1

Interventions

ruxolitinib 5 fludarabine 3 Cyclophosphamide 3 Whole-Body Irradiation 2 Tacrolimus 2 Stem Cell Transplantation 2 Specimen Handling 2 venetoclax 1 veliparib 1 selinexor 1 pevonedistat 1 merphos 1 iadademstat 1 fludarabine phosphate 1 fedratinib 1 decitabine and cedazuridine drug combination 1 bomedemstat 1 Topotecan 1 Panobinostat 1 Mycophenolic Acid 1 Methotrexate 1 Melphalan 1 Janus Kinase Inhibitors 1 Injections 1 INCB057643 1 Granulocyte Colony-Stimulating Factor 1 Decitabine 1 Cyclosporine 1 Carboplatin 1 Busulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡